---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-018543"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T15:11:35.071755+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nuwellis Q1 2025 revenue $1.9M (+3% YoY); net loss narrows to $3.0M

## Summary
- Revenue $1.9M (+3% YoY); consumables utilization +4%; pediatric revenue +38%.
- Operating expenses down 31% to $4.1M; operating loss improved to $3.1M from $4.7M.
- Net loss $3.0M ($0.69/sh) vs $3.8M ($24.11/sh) in Q1 2024.
- CMS reassigned Aquadex to higher outpatient reimbursement (4x to $1,639/day) effective Jan 1, 2025.
- Cash $2.6M, debt-free.

## SEC filing metadata
- accession: 0001140361-25-018543
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036125018543/0001140361-25-018543-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036125018543/ef20048675_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-018543
- JSON: https://secwatch.observer/filing/0001140361-25-018543.json
- Plain text: https://secwatch.observer/filing/0001140361-25-018543.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.